Viral Hepatitis News

I wasn’t so much hooked as I was hoodwinked!

A 1-year fellowship for senior trainees and early career infectious diseases physicians can help establish relationships with public health agencies and is an effective career development pathway, according to a study.

Hepatitis C primary infection and reinfection incidences declined after the introduction of access to direct-acting antiviral hepatitis C treatments, researchers found.

Study results suggest that WHO’s triple testing campaign for HIV, hepatitis B and hepatitis C should be expanded and not just target the three groups WHO listed to be most at risk, researchers said.

Scaling up hepatitis C testing and treatment in prisons effectively reduced HCV incidence and was a cost-effective option compared with existing services, data from a study in Australian prisons showed.

As viral hepatitis continues to be a major health concern in the infectious disease field, recent research has highlighted the importance of testing and treatment.

The front page of Healio | Infectious Disease News this year included stories about COVID-19, new vaccines, reversing decades of ID dogma, and more.

To mark the end of 2023, we compiled a list of this year’s Pharmacology Consult columns, in which our contributing PharmDs dig deep into the newest research to report on emerging therapies and vaccines for infectious diseases.

For the past 5 years, we have asked infectious disease clinicians to tell us when and why they chose a career in ID.

Nearly twice as many hepatitis A virus-related deaths were reported in the United States from 2016 to 2022 compared with the previous 6 years, with individuals who use drugs or experience homelessness and unstable housing most at risk.